Substance abuse/dependence treatment: a European perspective (Q38207160)

31 August 2017

title

Substance abuse/dependence treatment: a European perspective (English)

1 reference

31 August 2017

Laura Brandt

2

0 references

Verena E Metz

series ordinal

1

object named as

Verena E Metz

1 reference

31 August 2017

Annemarie Unger

3

1 reference

31 August 2017

Gabriele Fischer

series ordinal

4

1 reference

31 August 2017

publication date

1 July 2014

1 reference

31 August 2017

1 reference

31 August 2017

volume

35

1 reference

31 August 2017

issue

3

1 reference

31 August 2017

page(s)

309-320

1 reference

The size and burden of mental disorders and other disorders of the brain in Europe 2010.

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Cost of addiction in Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Size and burden of mental disorders in Europe—a critical review and appraisal of 27 studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Drug harms in the UK: a multicriteria decision analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Differences in drug consumption, comorbidity and health service use of opioid addicts across six European urban regions (TREAT-project).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

European youth care sites serve different populations of adolescents with cannabis use disorder. Baseline and referral data from the INCANT trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Welfare, temperance and compulsory commitment to care for persons with substance misuse problems: a comparative study of 38 European countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Healthcare financing systems for increasing the use of tobacco dependence treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Influence of site differences between urban and rural American and Central European opioid-dependent pregnant women and neonatal outcome characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

The neurobiology, clinical efficacy and safety of acamprosate in the treatment of alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Acamprosate for alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Acamprosate for the treatment of alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

The European NEAT program: an integrated approach using acamprosate and psychosocial support for the prevention of relapse in alcohol-dependent patients with a statistical modeling of therapy success prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Acamprosate supports abstinence, naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Combined therapy: what does acamprosate and naltrexone combination tell us?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

New achievements and pharmacotherapeutic approaches in the treatment of alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Extending the treatment options in alcohol dependence: a randomized controlled study of as-needed nalmefene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Effectiveness of screening and brief alcohol intervention in primary care (SIPS trial): pragmatic cluster randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Nicotine replacement therapy for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Pharmacotherapy for smoking cessation: present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Antidepressants for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

An increase in primary care prescriptions of stop-smoking medication as a result of health insurance coverage in the Netherlands: population based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Reimbursement for smoking cessation treatment may double the abstinence rate: results of a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

A meta-analytic review of psychosocial interventions for substance use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Interventions for promoting smoking cessation during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Financial incentives for smoking cessation among pregnant and newly postpartum women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Lessons learned from a comparison of evidence-based research in pregnant opioid-dependent women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Pharmacotherapies for cannabis withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Marijuana Withdrawal in Humans: Effects of Oral THC or Divalproex

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Combining cognitive behavioral therapy and contingency management to enhance their effects in treating cannabis dependence: less can be more, more or less

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Behavioral treatment for marijuana dependence: randomized trial of contingency management and self-efficacy enhancement

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Contingency management in community programs treating adolescent substance abuse: a feasibility study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Novel pharmacotherapeutic treatments for cocaine addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Efficacy of Psychostimulant Drugs for Cocaine Dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Efficacy of psychostimulant drugs for amphetamine abuse or dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Disulfiram for the treatment of cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Effectiveness of current treatment approaches for benzodiazepine discontinuation: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Office-based treatment in opioid dependence: a critical survey of prescription practices for opioid maintenance medications and concomitant benzodiazepines in Vienna, Austria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Buprenorphine and buprenorphine/naloxone diversion, misuse, and illicit use: an international review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

French field experience with buprenorphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

A prospective, randomized, multicenter acceptability and safety study of direct buprenorphine/naloxone induction in heroin-dependent individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Abuse liability of intravenous buprenorphine/naloxone and buprenorphine alone in buprenorphine-maintained intravenous heroin abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Pharmacokinetics of the combination tablet of buprenorphine and naloxone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Induction of opioid-dependent individuals onto buprenorphine and buprenorphine/naloxone soluble-films

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Comparative study of the effectiveness of slow-release morphine and methadone for opioid maintenance therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Use of slow-release oral morphine for the treatment of opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Slow-release oral morphine for maintenance treatment of opioid addicts intolerant to methadone or with inadequate withdrawal suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Slow-release oral morphine sulfate abuse: results of the postmarketing surveillance systems for psychoactive prescription drug abuse in France

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Misuse of medicines in the European Union: a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Methadone at tapered doses for the management of opioid withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Oral naltrexone maintenance treatment for opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Retention in naltrexone implant treatment for opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Improving clinical outcomes in treating heroin dependence: randomized, controlled trial of oral or implant naltrexone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Randomized trial of long-acting sustained-release naltrexone implant vs oral naltrexone or placebo for preventing relapse to opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Maintenance agonist treatments for opiate dependent pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Neonatal abstinence syndrome after methadone or buprenorphine exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Identifying the gap between need and intervention for alcohol use disorders in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

A survey of tobacco dependence treatment services in 36 countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Hepatitis C prevalence in injecting drug users in Europe, 1990-2007: impact of study recruitment setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Contemporary costs of HIV healthcare in the HAART era

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

Direct economic burden of chronic hepatitis C virus in a United States managed care population

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

HIV prevention cost-effectiveness: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2014.909377

10.1080/08897077.2014.909377

21 January 2018

Identifiers

DOI

1 reference

31 August 2017

1 reference